208 related articles for article (PubMed ID: 35630835)
1. Immuno-Imaging (PET/SPECT)-Quo Vadis?
Kramer CS; Dimitrakopoulou-Strauss A
Molecules; 2022 May; 27(10):. PubMed ID: 35630835
[TBL] [Abstract][Full Text] [Related]
2. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
3. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT.
Dimitrakopoulou-Strauss A
Cancer Immunol Immunother; 2019 May; 68(5):813-822. PubMed ID: 30123922
[TBL] [Abstract][Full Text] [Related]
5. ImmunoPET imaging of human CD8
Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
[TBL] [Abstract][Full Text] [Related]
6. Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?
Verhoeff SR; van den Heuvel MM; van Herpen CML; Piet B; Aarntzen EHJG; Heskamp S
PET Clin; 2020 Jan; 15(1):35-43. PubMed ID: 31735300
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. The Value of
Vekens K; Everaert H; Neyns B; Ilsen B; Decoster L
Clin Lung Cancer; 2021 Sep; 22(5):432-440. PubMed ID: 33879398
[TBL] [Abstract][Full Text] [Related]
9. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
[No Abstract] [Full Text] [Related]
11. Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors.
Abenavoli EM; Linguanti F; Calabretta R; Delgado Bolton RC; Berti V; Lopci E
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067379
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Immuno-PET Tracer to Image PD-L1.
Wissler HL; Ehlerding EB; Lyu Z; Zhao Y; Zhang S; Eshraghi A; Buuh ZY; McGuth JC; Guan Y; Engle JW; Bartlett SJ; Voelz VA; Cai W; Wang RE
Mol Pharm; 2019 May; 16(5):2028-2036. PubMed ID: 30875232
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging to support cancer immunotherapy.
van de Donk PP; Oosting SF; Knapen DG; van der Wekken AJ; Brouwers AH; Lub-de Hooge MN; de Groot DA; de Vries EG
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35922089
[TBL] [Abstract][Full Text] [Related]
14.
Alves CRR; Faria DP; Carneiro CG; Garcez AT; Gutierrez VP; das Neves W; de Almeida NR; Cury Y; Chammas R; Brum PC
Life Sci; 2018 Aug; 206():29-34. PubMed ID: 29778807
[TBL] [Abstract][Full Text] [Related]
15. Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
Sharkey RM; Karacay H; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5577s-5585s. PubMed ID: 17875792
[TBL] [Abstract][Full Text] [Related]
16. Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.
Mayer AT; Natarajan A; Gordon SR; Maute RL; McCracken MN; Ring AM; Weissman IL; Gambhir SS
J Nucl Med; 2017 Apr; 58(4):538-546. PubMed ID: 27980047
[TBL] [Abstract][Full Text] [Related]
17.
Humbert O; Cadour N; Paquet M; Schiappa R; Poudenx M; Chardin D; Borchiellini D; Benisvy D; Ouvrier MJ; Zwarthoed C; Schiazza A; Ilie M; Ghalloussi H; Koulibaly PM; Darcourt J; Otto J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1158-1167. PubMed ID: 31760467
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
20. Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.
Beer L; Hochmair M; Haug AR; Schwabel B; Kifjak D; Wadsak W; Fuereder T; Fabikan H; Fazekas A; Schwab S; Mayerhoefer ME; Herold C; Prosch H
Clin Nucl Med; 2019 Jul; 44(7):535-543. PubMed ID: 31021918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
